| 1 杨柯君. 全球癌症状况最新数据更新[J]. 上海医药, 2014, 35(2): 5-5YANG Kejun. The latest data update of global cancer condition[J]. Shanghai Med J, 2014, 35(2): 5-52 Dosoretz D E, Katin M J, Blitzer P H, et al. Medically inoperable lung carcinoma: the role of radiation therapy[C]. Semin Radiat Oncol, 1996, 6(2):98-1043 Jang M, Cai L, Udeani G O, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes[J]. Science, 1997, 275(5297):218-2204 John L, Ingham. 3, 5, 4’-Trihydroxystilbene as a phytoalexin from groundnuts (Arachis hypogea)[J]. Phytochemistry, 1976, 15(11): 1791-19735 Song R, Li W Q, Dou J L, et al. Resveratrol reduces inflammatory cytokines via inhibiting nuclear factor-κB and mitogen-activated protein kinase signal pathway in a rabbit atherosclerosis model[J]. Chin J Cardiol, 2013, 41(10): 866-8696 Lodovici M, Bigagli E, Luceri C, et al. Protective Effect of Resveratrol against Oxidation Stress Induced by 2-Nitropropane in Rat Liver[J]. J Pharm Pharmacol, 2011, 2(03): 127-1357 He X, Wang Y, Zhu J, et al. Resveratrol enhances the anti-tumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycin-induced AKT signaling[J]. Cancer lett, 2011, 301(2): 168-1768 Scarlatti F, Sala G, Ricci C, et al. Resveratrol sensitization of DU145 prostate cancer cells to ionizing radiation is associated to ceramide increase[J]. Cancer lett, 2007, 253(1): 124-1309 Baatout, Derradji, Jacquet, et al. Enhanced radiation-induced apoptosis of cancer Cell lines after treatment with resveratrol[J]. Int J Mol Med, 2004, 13(6): 895-90210 Luo H, Wang L, Schulte B A, et al. Resveratrol enhances ionizing radiation-induced premature senescence in lung cancer cells[J]. Int J Oncol, 2013, 43(6): 1999-200611叶娟平, 刘韬, 戴昆怡, 等. 放射增敏剂的临床研究进展[J]. 医药导报, 2009, 28（7）: 893-896YE Juanping, LIU Tao, DAI Kunyi, et al. Clinical research progress of radiosensitizer[J]. Her Med, 2009, 28（7）: 893-89612 Gupta S C, Kannappan R, Reuter S, et al. Chemosensitization of tumors by resveratrol[J]. Ann NY Acad Sci, 2011, 1215(1): 150-16013 Sale S, Tunstall R G, Ruparelia K C, et al. Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3, 4, 5, 4′‐tetramethoxystilbene (DMU‐212) on adenoma development in the ApcMin+ mouse and cyclooxygenase‐2 in human‐derived colon cancer cells[J]. Int J Cancer, 2005, 115(2): 194-20114 Gullett N P, Ruhul Amin A R M, Bayraktar S, et al. Cancer prevention with natural compounds[C]. Semin Oncol. WB Saunders, 2010, 37(3): 258-28115 Bhat K P L, Lantvit D, Christov K, et al.Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models[J]. Cancer Res, 2001, 61(20): 7456-746316 Gupta S C, Kannappan R, Reuter S, et al. Chemosensitization of tumors by resveratrol[J]. Ann N Y Acad Sci, 2011, 1215(1): 150-16017 Fang Y, DeMarco V G, Nicholl M B. Resveratrol enhances radiation sensitivity in prostate cancer by inhibiting cell proliferation and promoting cell senescence and apoptosis[J]. Cancer Sci, 2012, 103(6): 1090-109818 Boocock D J, Faust G E S, Patel K R, et al. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent[J]. Cancer Epidemiology Biomarkers Prev, 2007, 16(6): 1246-125219 Jin X, Li Q, Wu Q, et al.Radiosensitization by inhibiting survivin in human hepatoma HepG2 cells to high-LET radiation[J]. J Radiat Res, 2011, 52(3): 335-34120 Asanuma K, Moriai R, Yajima T, et al. Survivin as a radioresistance factor in pancreatic cancer[J]. Int J Mol Sci, 2000, 91(11): 1204-1209 |
